Jiuqiang Bio: Shareholders plan to terminate the agreement to transfer 5.0000003% of the company's shares.

Jiuqiang Biology Announcement: The share transfer agreement signed by the company's shareholders Zou Zuojun, Liu Xi, Sun Xiaolin and China National Pharmaceutical Investment has been terminated. The original agreement stipulated the transfer of 29.3154 million shares, accounting for 5.0000003% of the total share capital of the company. The total transfer price for this transaction was 401 million yuan. The reason for termination was that as of December 31, 2025, the shares subject to the agreement had not been successfully transferred for registration.